Biogen Inc

Biogen insider buying signals cautious optimism amid Apellis deal – insider Sean Godbout’s recent trades suggest strategic confidence and potential price rebound.

Biogen CEO’s February trades show confidence, with a modest net purchase amid routine vesting—insider activity signals growth optimism, not market moves.

Biogen insider buy by Head of Development signals confidence before earnings; assess how it may boost stock and guide investor decisions.